SYNH stock forecast
Our latest prediction for Syneos Health Inc's stock price was made on the June 7, 2021 when the stock price was at 80.71$.
In the short term (2weeks), SYNH's stock price should underperform the market by -0.77%. During that period the price should oscillate between -5.59% and +4.34%.
In the medium term (3months), SYNH's stock price should underperform the market by -1.69%. During that period the price should oscillate between -16.07% and +11.13%.Get email alerts
Create a solid portfolio with SYNH
About Syneos Health Inc
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.
At the moment the company generates 4461M USD in revenues.
On its last earning announcement, the company reported a profit of 1.88$ per share.
The book value per share is 27.43$
Three months stock forecastJune 7, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|